BULKGLP RESEARCH LIBRARY
Retatrutide Research Guide
Published
Retatrutide is a modified peptide studied as an agonist of GLP-1, GIP, and glucagon receptors; evaluating a laboratory lot requires separate evidence of identity, purity, and content.
At a glance
- Its three receptor targets are GLP-1R, GIPR, and GCGR.
- Sequence substitutions and a fatty diacid attachment serve different molecular functions.
- Published receptor experiments characterize the studied molecule; they do not certify another supplier's lot.
What defines the molecule
Also identified as LY3437943, retatrutide has a 39-residue backbone engineered from GIP. The noncanonical residue α-aminoisobutyric acid (Aib) at position 2 provides resistance to DPP-4 cleavage. Aib at position 20 and α-methyl-L-leucine at position 13 contribute to its receptor activity profile. A C20 fatty diacid is attached through a linker at lysine 17, enabling albumin binding. These features are described in Coskun and colleagues' molecular characterization.
Read receptor results in context
- Binding affinity
- How strongly a ligand interacts with a receptor under defined conditions, typically described using Kd or Ki.
- Functional potency
- The concentration producing a specified response. An EC50 in a cAMP assay describes half the measured maximal response, rather than binding strength.
- Maximum response
- The response achievable in that assay. It must be considered alongside potency.
Record the receptor species, cell model, receptor expression, endpoint, incubation time, and albumin conditions when comparing experiments. Albumin can bind acylated peptides and alter the free concentration available to receptors. A lower EC50 from a different assay does not establish universally stronger activity.
Check the material before an experiment
- Match the vial's lot identifier to the report and confirm the specified sequence, modifications, and salt form.
- Check the HPLC method, detection wavelength, chromatogram, and integration basis.
- Review the LC-MS charge assignment and expected mass; an intact mass match supports identity but cannot establish every structural detail.
- Identify any quantitative content measurement, residual-water result, and documented storage or retest conditions.
HPLC area percentage is not the peptide mass fraction of the powder. Counterions and residual water can contribute to its weight, as explained in Bachem's analytical FAQ. Use the COA interpretation guide to assess those measurements and the receptor mechanisms overview to compare assay types.